United Kingdom

Verdiva Bio launches with €398.4M to revolutionize Obesity Treatment
Verdiva Bio Limited, a London-based clinical-stage biopharmaceutical company, has launched with a €398.4 million ($411M USD) Series A funding round.

The best Articles in our Network

Previous
Next